The Priority Review

Tag

APHRS

1 story

Stories

  1. Clinical trials

    Medtronic reports positive real-world registry results for Sphere-9 and PulseSelect at APHRS 2026

    Medtronic said the APEX registry included 1,050 patients with atrial fibrillation treated with the Sphere-9 catheter, reporting a 1.1% major complication rate. The REAL PULSE registry included 1,160 patients and reported a 100% acute success rate with a 0.09% acute major complication rate.